| Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization–systematic review and recommendations from the HS ALLIANCE working group CC Zouboulis, FG Bechara, JL Dickinson‐Blok, W Gulliver, B Horváth, ... Journal of the European Academy of Dermatology and Venereology 33 (1), 19-31, 2019 | 234 | 2019 |
| Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis JE Gudjonsson, LC Tsoi, F Ma, AC Billi, KR Van Straalen, A Vossen, ... JCI insight 5 (19), 2020 | 117 | 2020 |
| Menses and pregnancy affect symptoms in hidradenitis suppurativa: A cross-sectional study ARJV Vossen, KR van Straalen, EP Prens, HH van der Zee Journal of the American Academy of Dermatology 76 (1), 155-156, 2017 | 71 | 2017 |
| Assessing pruritus in hidradenitis suppurativa: a cross-sectional study ARJV Vossen, A Schoenmakers, KR van Straalen, EP Prens, ... American journal of clinical dermatology 18, 687-695, 2017 | 59 | 2017 |
| The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: results of a prospective European cohort study KR van Straalen, T Tzellos, P Guillem, F Benhadou, C Cuenca-Barrales, ... Journal of the American Academy of Dermatology 85 (2), 369-378, 2021 | 51 | 2021 |
| Current and future treatment of hidradenitis suppurativa KR Van Straalen, S Schneider‐Burrus, EP Prens British Journal of Dermatology 183 (6), e178-e187, 2020 | 45 | 2020 |
| Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross‐sectional study among 2465 patients F Benhadou, HH Van der Zee, JC Pascual, D Rigopoulos, A Katoulis, ... British Journal of Dermatology 181 (6), 1198-1206, 2019 | 44 | 2019 |
| Contribution of genetics to the susceptibility to hidradenitis suppurativa in a large, cross-sectional Dutch twin cohort KR Van Straalen, EP Prens, G Willemsen, DI Boomsma, HH Van Der Zee JAMA dermatology 156 (12), 1359-1362, 2020 | 41 | 2020 |
| Correlation of the refined Hurley classification for hidradenitis suppurativa with patient‐reported quality of life and objective disease severity assessment A Rondags, KR van Straalen, JR van Hasselt, IC Janse, CB Ardon, ... British Journal of Dermatology 180 (5), 1214-1220, 2019 | 32 | 2019 |
| Insights into hidradenitis suppurativa KR van Straalen, EP Prens, JE Gudjonsson Journal of Allergy and Clinical Immunology 149 (4), 1150-1161, 2022 | 31 | 2022 |
| Clinical implementation of biologics and small molecules in the treatment of hidradenitis suppurativa P Aarts, K Dudink, ARJV Vossen, KR van Straalen, CB Ardon, EP Prens, ... Drugs 81 (12), 1397-1410, 2021 | 30 | 2021 |
| Hurley III hidradenitis suppurativa has an aggressive disease course AMJD Vanlaerhoven, CB Ardon, KR van Straalen, ARJV Vossen, ... Dermatology (Basel, Switzerland) 234 (5-6), 232, 2018 | 29 | 2018 |
| Poor interrater reliability of hidradenitis suppurativa phenotypes KR van Straalen, T Verhagen, B Horváth, C Ardon, ARJV Vossen, ... Journal of the American Academy of Dermatology 79 (3), 577-578, 2018 | 28 | 2018 |
| A novel nicastrin mutation in a three‐generation Dutch family with hidradenitis suppurativa: a search for functional significance A Vossen, KR van Straalen, SMA Swagemakers, J de Klein, AP Stubbs, ... Journal of the European Academy of Dermatology and Venereology 34 (10), 2353 …, 2020 | 25 | 2020 |
| Development and validation of IHS4‐55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa T Tzellos, KR van Straalen, A Kyrgidis, A Alavi, N Goldfarb, W Gulliver, ... Journal of the European Academy of Dermatology and Venereology 37 (2), 395-401, 2023 | 22 | 2023 |
| Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study K Dudink, K Bouwman, Y Chen, SE DePrimo, EJ Munoz-Elias, P Aarts, ... British Journal of Dermatology 188 (5), 601-609, 2023 | 20 | 2023 |
| Impact of hidradenitis suppurativa on work productivity and associated risk factors KR van Straalen, LM Prens, TH Hylkema, IC Janse, J Dickinson, ... Journal of the American Academy of Dermatology 84 (5), 1401-1405, 2021 | 20 | 2021 |
| High prevalence of clinical spondyloarthritis features in patients with hidradenitis suppurativa A Rondags, KR van Straalen, S Arends, HH van der Zee, EP Prens, ... Journal of the American Academy of Dermatology 80 (2), 551-554. e1, 2019 | 20 | 2019 |
| Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study LM Prens, K Bouwman, P Aarts, S Arends, KR van Straalen, K Dudink, ... British Journal of Dermatology 185 (1), 177-184, 2021 | 18 | 2021 |
| Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders P Aarts, ARJV Vossen, HH van der Zee, EP Prens, KR van Straalen Journal of the American Academy of Dermatology 85 (1), 258-260, 2021 | 18 | 2021 |
Hessel H van der zeeVerified email at erasmusmc.nl
